Karin U. Travers

2.8k citations
36 papers · 2.2k · 1 hit paper · h-index 17

Impact in

  • Virology top 0.5%
    • HIV Research and Treatment
    • HIV/AIDS Research and Interventions
    • HIV/AIDS drug development and treatment

Papers in

    • HIV Research and Treatment 11
    • HIV/AIDS Research and Interventions 8
    • Viral gastroenteritis research and epidemiology 2

Karin U. Travers

36 papers receiving 2.1k citations

Karin U. Travers's Hit Papers

Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1 1994 · 484 citations
4840+10+21Years since publication100200300400

Peers

Karin U. Travers
Comparison fields: 5 of 111
  • Virology 1.1k
  • Infectious Diseases 830
  • Applied Microbiology and Biotechnology 50
  • Molecular Medicine 127
  • Otorhinolaryngology 60
Replace Heba H. Mostafa with:
Heba H. Mostafa United States
Paul A Krogstad United States
Maphoshane Nchabeleng South Africa
Dominique Peyramond France
Robert J. Leggiadro United States
Leonard N. Slater United States
Christian T. Bautista United States
Michael L. Landrum United States
Pierre Robert Smeesters Belgium
Larry I. Lutwick United States
Karin U. Travers relative to Heba H. Mostafa United States Heba H. Mostafa's profile →
Citations per field
00.5×2×4×6.0×
Heba H. Mostafa · 1×
Citations per year

Countries citing papers authored by Karin U. Travers

Since Specialization
Citations

This map shows the geographic impact of Karin U. Travers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin U. Travers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin U. Travers more than expected).

Fields of papers citing papers by Karin U. Travers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin U. Travers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin U. Travers. The network helps show where Karin U. Travers may publish in the future.

Co-authors

The 25 scholars most cited alongside Karin U. Travers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karin U. Travers Line = papers co-authored together Karin U. Travers links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1
Hit paper breakdown →
1994484
2 1994288
3 1999189
4 1995169
5 2002154
6 2014127
7 2011122
8 2002108
9 198791
10 199284
11 200556
12 201635
13 201933
14 199629
15 200229
16 201323
17 201923
18 201217
19 200015
20 201315

About Karin U. Travers

Karin U. Travers is a scholar working on Virology, Infectious Diseases, Reproductive Medicine, Oncology and Agronomy and Crop Science, having authored 36 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (8 papers), PARP inhibition in cancer therapy (5 papers), Ovarian cancer diagnosis and treatment (4 papers), Animal Disease Management and Epidemiology (3 papers), T-cell and Retrovirus Studies (3 papers), Sex work and related issues (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (830 citations), Applied Microbiology and Biotechnology (50 citations), Molecular Medicine (127 citations) and Otorhinolaryngology (60 citations). Karin U. Travers has collaborated with scholars based in United States, Senegal and United Kingdom. Frequent co-authors include Michael J. Barza, Phyllis J. Kanki, Souleymane Mboup, Aïssatou Guèye‐Ndiaye, Richard Marlink, Max Essex, Tidiane Siby, Ibrahima Ndoye, Ibou Thior and Jean‐Louis Sankalé. Their work appears in journals such as Science, Clinical Infectious Diseases, International Journal of Gynecological Cancer, JAIDS Journal of Acquired Immune Deficiency Syndromes and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact